Clinical trial
Phase Ib Trial of MSP3 LSP in Children in Tanzania
NCT00469651 · African Malaria Network Trust, Other · Unknown status
Key facts
| NCT number | NCT00469651 |
|---|---|
| Title | Phase Ib Trial of MSP3 LSP in Children in Tanzania |
| Official title | A Double Blind, Randomized, Controlled Phase Ib Field Trial in 12 to 24 Month Old Children in Tanzania to Evaluate the Safety and Immunogenicity of Candidate Malaria Vaccine MSP 3 Versus Hepatitis B Vaccine |
| Acronym | MSP3TN |
| Lead sponsor | African Malaria Network Trust, Other |
| Collaborators | London School of Hygiene and Tropical Medicine |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Biological |
| Interventions | MSP 3 Long Synthetic Peptide, MSP3 vaccine, Hepatitis B vaccine, MSP3 candidate vaccine, Hepatitis B control vaccine |
| Enrollment | 45 |
| Start date | Oct 1, 2007 |
| Completion | Aug 1, 2008 |
| First posted | May 4, 2007 |
| Last update posted | Dec 14, 2007 |
| Countries | Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: